News

News

YSOPIA Bioscience secures €1.55M in non-dilutive funding from Bpifrance and the European Regional...

Nov 17, 2020

more +
News

We are looking for a R&D Microbiologist

Oct 13, 2020

more +
News

LNC Therapeutics becomes YSOPIA Bioscience marking its transition to a clinical stage company

Sep 29, 2020

more +
News

LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...

Sep 8, 2020

more +
News

LNC Therapeutics announces the acquisition of an exclusive worldwide license on the first patent...

Apr 15, 2020

more +
News

LNC Therapeutics Announces Successful GMP Manufacturing of Xla1 for Phase 1 Clinical Trial

Mar 12, 2020

more +

YSOPIA Bioscience © 2020 - all rights reserved terms and conditions